drugset / Trial / NCT02149420
PD of VAY736 in Patients With Primary Sjögren's Syndrome
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study was designed to evaluate the safety, tolerability, pharmacokinetics and therapeutic efficacy of a single intravenous infusion of VAY7346 monoclonal antibody in pSS patients
Timeline
- Start
- 2014-05-23
- Primary completion
- 2018-02-07
- Completion
- 2018-02-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ianalumab | Monoclonal antibody | 3 mg/kg | Intravenous |
| Subject | Ianalumab | Monoclonal antibody | 10 mg/kg | Intravenous |